Tags

Type your tag names separated by a space and hit enter

Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors.
Eur J Med Chem. 2008 Dec; 43(12):2724-34.EJ

Abstract

In this study, a series of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors were taken as our target with the method of the three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses in order to investigate the interactions between CCR5 receptor and their inhibitors. For a comparison, Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) were, respectively, used to build predictive models, which were generated from a training set consisting of 72 selected molecules, derived from literatures. Two alignment rules, including rigid body rms (root mean square) fit and field fit, were performed in the superimposition of inhibitors structures. As a result, a better CoMFA model based on common structure alignment obtains a conventional correlation coefficient r(2) of 0.952 and a leave-one-out cross-validated coefficient q(2) of 0.637, while the desirable CoMSIA model based on the same alignment rule acquires the r(2) of 0.958 and the q(2) of 0.677. To further validate the reliability of the models, we also investigated into the externally test set composed of 39 molecules under the criterions of squared correlation coefficient between experimental and predicted activities with intercept R(2) and without intercept R(0)(2), along with R(m)(2) as the modified R(2) with a penalty function due to difference between R(2) and R(0)(2). At last, the contour map also provides a visual representation of contributions of steric, electrostatic, hydrogen bond and hydrophobic fields, as well as the prospective binding modes. These results may provide meaningful guidance to the further work including the similar lead compounds' structure modification and activity prediction.

Authors+Show Affiliations

College of Life Science and Bioengineering, Beijing University of Technology, Ping Le Yuan 100, Chao Yang District, Beijing 100124, China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18538451

Citation

Zhuo, Ya, et al. "Three-dimensional QSAR Analyses of 1,3,4-trisubstituted Pyrrolidine-based CCR5 Receptor Inhibitors." European Journal of Medicinal Chemistry, vol. 43, no. 12, 2008, pp. 2724-34.
Zhuo Y, Kong R, Cong XJ, et al. Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors. Eur J Med Chem. 2008;43(12):2724-34.
Zhuo, Y., Kong, R., Cong, X. J., Chen, W. Z., & Wang, C. X. (2008). Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors. European Journal of Medicinal Chemistry, 43(12), 2724-34. https://doi.org/10.1016/j.ejmech.2008.01.040
Zhuo Y, et al. Three-dimensional QSAR Analyses of 1,3,4-trisubstituted Pyrrolidine-based CCR5 Receptor Inhibitors. Eur J Med Chem. 2008;43(12):2724-34. PubMed PMID: 18538451.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors. AU - Zhuo,Ya, AU - Kong,Ren, AU - Cong,Xiao-jing, AU - Chen,Wei-zu, AU - Wang,Cun-xin, Y1 - 2008/02/08/ PY - 2007/11/13/received PY - 2008/01/14/revised PY - 2008/01/14/accepted PY - 2008/6/10/pubmed PY - 2009/3/3/medline PY - 2008/6/10/entrez SP - 2724 EP - 34 JF - European journal of medicinal chemistry JO - Eur J Med Chem VL - 43 IS - 12 N2 - In this study, a series of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors were taken as our target with the method of the three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses in order to investigate the interactions between CCR5 receptor and their inhibitors. For a comparison, Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) were, respectively, used to build predictive models, which were generated from a training set consisting of 72 selected molecules, derived from literatures. Two alignment rules, including rigid body rms (root mean square) fit and field fit, were performed in the superimposition of inhibitors structures. As a result, a better CoMFA model based on common structure alignment obtains a conventional correlation coefficient r(2) of 0.952 and a leave-one-out cross-validated coefficient q(2) of 0.637, while the desirable CoMSIA model based on the same alignment rule acquires the r(2) of 0.958 and the q(2) of 0.677. To further validate the reliability of the models, we also investigated into the externally test set composed of 39 molecules under the criterions of squared correlation coefficient between experimental and predicted activities with intercept R(2) and without intercept R(0)(2), along with R(m)(2) as the modified R(2) with a penalty function due to difference between R(2) and R(0)(2). At last, the contour map also provides a visual representation of contributions of steric, electrostatic, hydrogen bond and hydrophobic fields, as well as the prospective binding modes. These results may provide meaningful guidance to the further work including the similar lead compounds' structure modification and activity prediction. SN - 1768-3254 UR - https://www.unboundmedicine.com/medline/citation/18538451/Three_dimensional_QSAR_analyses_of_134_trisubstituted_pyrrolidine_based_CCR5_receptor_inhibitors_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0223-5234(08)00050-0 DB - PRIME DP - Unbound Medicine ER -